Commission closes antitrust investigation following the withdrawal by Edwards Lifesciences of its disputed company policy

The European Commission has decided to close its antitrust investigation into allegedly anticompetitive behaviour by Edwards Lifesciences, a producer of medical devices for cardiovascular applications. The closure of the investigation follows the company's withdrawal of its so-called Global Unilateral Pro-Innovation (Anti-Copycatting) Policy ('UPIP'). Hence, the UPIP is no longer applicable and has been removed from the company's […]